4.7 Editorial Material

Sepsis studies need new direction

期刊

LANCET INFECTIOUS DISEASES
卷 12, 期 7, 页码 503-505

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/S1473-3099(12)70136-6

关键词

-

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Macrophage migration inhibitory factor promotes the migration of dendritic cells through CD74 and the activation of the Src/PI3K/myosin II pathway

Annette Ives, Didier Le Roy, Charlotte Theroude, Juergen Bernhagen, Thierry Roger, Thierry Calandra

Summary: The cytokine MIF plays a chemokine-like role in promoting the migration of dendritic cells (DCs) by activating the Src/PI3K signaling pathway and myosin II complexes. MIF contributes to the recruitment of DCs to draining lymph nodes through autocrine and paracrine activities acting via CD74. These findings indicate that MIF is crucial for DC motility and trafficking.

FASEB JOURNAL (2021)

Review Infectious Diseases

Impact of the timeliness of antibiotic therapy on the outcome of patients with sepsis and septic shock

Sandra A. Asner, Florian Desgranges, Irene T. Schrijver, Thierry Calandra

Summary: The study reviewed the impact of the timeliness of antibiotic therapy on the outcome of patients with sepsis or septic shock. It found that early administration of antibiotic therapy was associated with patient outcome, but there were significant differences in antibiotic therapy time thresholds across studies and no robust time thresholds emerged.

JOURNAL OF INFECTION (2021)

Article Infectious Diseases

High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus

Jacobus Herderschee, Tytti Heinonen, Craig Fenwick, Irene T. Schrijver, Khalid Ohmiti, Darius Moradpour, Matthias Cavassini, Giuseppe Pantaleo, Thierry Roger, Thierry Calandra

Summary: Chronic hepatitis C virus (HCV) and HCV/HIV infections have profound and durable effects on immune homeostasis, which persist even after treatment with direct-acting antivirals (DAA).

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Letter Infectious Diseases

Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period

C. Lazor-Blanchet, P. Zygoura, U. Dafni, F. Lamoth, Z. Tsourti, M. A. Lobritz, J. Regina, B. Grandbastien, C. Fenwick, G. Pantaleo, T. Calandra, S. Meylan

JOURNAL OF INFECTION (2022)

Article Critical Care Medicine

High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumonia and sepsis with multi-organ failure

Irene T. Schrijver, Eleni Karakike, Charlotte Theroude, Petra Baumgartner, Alexandre Harari, Evangelos J. Giamarellos-Bourboulis, Thierry Calandra, Thierry Roger

Summary: This is the first study to associate high levels of M-MDSCs with improved survival in sepsis patients.

INTENSIVE CARE MEDICINE EXPERIMENTAL (2022)

Review Oncology

Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)

Georg Maschmeyer, Lars Bullinger, Carolina Garcia-Vidal, Raoul Herbrecht, Johan Maertens, Pierantonio Menna, Livio Pagano, Anne Thiebaut-Bertrand, Thierry Calandra

Summary: The 9th web-based European Conference on Infections in Leukemia (ECIL-9) reviewed the risk of infections and febrile neutropenia associated with newer immunotherapeutic agents and molecular targeted drugs for the treatment of AML and ALL. Evidence-based recommendations were developed and discussed for prevention and management of infectious complications, as well as drug-drug interactions.

LEUKEMIA (2022)

Editorial Material Immunology

COVID-19 rapidly increases MDSCs and prolongs innate immune dysfunctions

Irene T. Schrijver, Charlotte Theroude, Nikolaos Antonakos, Jean Regina, Didier Le Roy, Pierre-Alexandre Bart, Jean-Daniel Chiche, Matthieu Perreau, Giuseppe Pantaleo, Thierry Calandra, Thierry Roger

EUROPEAN JOURNAL OF IMMUNOLOGY (2022)

Letter Infectious Diseases

Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, non-neutropenic, adult patients: An update including COVID-19 data

Matteo Bassetti, Valentina Zuccaro, Erika Asperges, Luigia Scudeller, Daniele Roberto Giacobbe

JOURNAL OF INFECTION (2022)

Review Dermatology

Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence synthesis

Daniele Roberto Giacobbe, Erika Asperges, Andrea Cortegiani, Cecilia Grecchi, Chiara Rebuffi, Valentina Zuccaro, Luigia Scudeller, Matteo Bassetti

Summary: This systematic review summarizes the diagnostic performance of clinical scores and laboratory tests for invasive candidiasis (IC) in critically ill, nonneutropenic adult patients in the Intensive Care Unit (ICU). Clinical scores consistently showed a high negative predictive value (NPV) and a low positive predictive value (PPV), while fungal antigen-based biomarkers retained a high NPV similar to clinical scores with a higher PPV but with heterogeneity across studies.

MYCOSES (2022)

Article Immunology

Κey Role of Early Source Control in Candidemic Patients With Sepsis or Septic Shock

Matthaios Papadimitriou-Olivgeris, Julien Battistolo, Julien Poissy, Alix Coste, Pierre-Yves Bochud, Thierry Calandra, Laurence Senn, Frederic Lamoth

Summary: This study analyzed the predictors of mortality in patients with candidemia and found that early source control, particularly vascular catheter removal, was a key determinant of outcome in patients with sepsis or septic shock.

OPEN FORUM INFECTIOUS DISEASES (2022)

Article Infectious Diseases

National Early Warning Score (NEWS) Outperforms Quick Sepsis-Related Organ Failure (qSOFA) Score for Early Detection of Sepsis in the Emergency Department

Dimitri Durr, Tapio Niemi, Jeremie Despraz, Selin Tusgul, Fabrice Dami, Rachid Akrour, Pierre-Nicolas Carron, Marie-Annick Le Pogam, Thierry Calandra, Sylvain Meylan

Summary: In emergency department patients with suspected sepsis, NEWS score had higher sensitivity while qSOFA score had higher specificity and positive predictive values.

ANTIBIOTICS-BASEL (2022)

Article Medicine, General & Internal

ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol

Antigone Kotsaki, Peter Pickkers, Michael Bauer, Thierry Calandra, Mihaela Lupse, W. Joost Wiersinga, Sylvain Meylan, Frank Bloos, Tom van der Poll, Marleen A. Slim, Niels van Mourik, Marcella C. A. Muller, Lonneke van Vught, Alexander P. J. Vlaar, Aline de Nooijer, Lieke Bakkerus, Sebastian Weis, Nikolaos Antonakos, Mihai G. Netea, Evangelos J. Giamarellos-Bourboulis

Summary: This study aims to investigate the efficacy of precision immunotherapy on sepsis patients, focusing on the phenotypes of MALS and immunoparalysis. The study utilizes a randomized placebo-controlled double-blind design and stratifies patients using biomarkers. The results will be published in peer-reviewed journals.

BMJ OPEN (2022)

Article Respiratory System

Pulmonary aspergillosis: diagnosis and treatment

Frederic Lamoth, Thierry Calandra

Summary: Aspergillus species are the most common cause of fungal infections of the lungs, including invasive pulmonary aspergillosis and chronic pulmonary aspergillosis. Invasive pulmonary aspergillosis primarily affects immunocompromised individuals, while chronic pulmonary aspergillosis primarily affects patients with pre-existing lung lesions. The diagnosis and management of pulmonary aspergillosis are both complex.

EUROPEAN RESPIRATORY REVIEW (2022)

Review Microbiology

What Is New in Pulmonary Mucormycosis?

Francois Danion, Anne Coste, Coralie Le Hyaric, Clea Melenotte, Frederic Lamoth, Thierry Calandra, Dea Garcia-Hermoso, Vishukumar Aimanianda, Fanny Lanternier, Olivier Lortholary

Summary: Mucormycosis is a rare and life-threatening fungal infection caused by molds of the order Mucorales. It mainly affects the lungs, following the rhino-orbito-cerebral (ROC) areas and the skin. Risk factors for pulmonary mucormycosis (PM) include hematological malignancies and solid organ transplantation, while ROC infections are commonly associated with diabetes mellitus. The diagnosis of PM relies on CT scans, cultures, PCR tests, and histology, and treatment involves liposomal amphotericin B as the first-line therapy.

JOURNAL OF FUNGI (2023)

暂无数据